Filing Flows › Traws Pharma (TRAW) › Q1 2025 › vs Q4 2024
Traws Pharma (TRAW) Q1 2025 vs Q4 2024 (quarter over quarter)
Traws Pharma's revenue rose $1K (+2%) from $56K in Q4 2024 to $57K in Q1 2025.
Traws Pharma, Q1 2025: revenue $57K (+2% year over year), net earnings $21.5M, operating cash flow −$5.4M. The chart draws each line against Q4 2024, the increases inside each band.
Every line
| Line | Q1 2025 | Q4 2024 | Change | % |
|---|---|---|---|---|
| Revenue | $57K | $56K | $1K | +2% |
| Other income, net | $26.7M | −$24.6M | $51.3M | — |
| Costs & expenses | $26.8M | $30.0M | −$3.2M | -11% |
| Operating costs | $5.3M | $5.3M | −$74K | -1% |
| Net earnings | $21.5M | −$29.9M | $51.4M | — |
| Research & development | $2.5M | $1.9M | $648K | +35% |
| General & admin | $2.8M | $3.5M | −$722K | -21% |
| Operating cash sources | $27.1M | −$25.5M | $52.6M | — |
| Depreciation & amortization | $1K | $2K | −$1K | -50% |
| Share-based compensation | $161K | $334K | −$173K | -52% |
| Cash used in operations | $5.4M | $4.0M | $1.4M | +35% |
| Working capital & other | $27.1M | −$25.5M | $52.6M | — |
Questions
How much did Traws Pharma's revenue grow quarter over quarter in Q1 2025?
Traws Pharma's revenue rose $1K (+2%) from $56K in Q4 2024 to $57K in Q1 2025.